Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Cha University

Clinical trials sponsored by Cha University, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • Scientists hunt for genetic signs to personalize bile duct cancer therapy Results expected Sep 2026 (estimated)
  • Blood test may replace biopsies for bile duct cancer patients Results expected Dec 2026 (estimated)
  • Suicide gene stem cells take aim at glioblastoma Results expected Dec 2026 (estimated)
  • Blood test could replace needle biopsies for bile duct cancer patients Results expected Aug 2027 (estimated)
  • Can an Anti-Inflammatory drug make liver cancer immunotherapy safer? Results expected Sep 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 8 Not yet recruiting 1 Not yet finished but already full! 1 Completed 5
Sort by
  • Can an Anti-Inflammatory drug make liver cancer immunotherapy safer?

    Disease control Not yet recruiting

    This phase II trial is testing whether adding tocilizumab, an anti-inflammatory drug, to a standard two-drug immunotherapy regimen can reduce severe immune-related side effects in people with advanced liver cancer. The study enrolls about 51 adults with hepatocellular carcinoma t…

    Phase 2 • Sponsor: CHA University • Aim: Disease control

    Last updated Aug 21, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space